New pill takes aim at Hard-to-Treat cancers
Disease control
Recruiting now
This trial tests an experimental drug called CP-383 in people with advanced solid tumors (like lung, colon, or pancreatic cancer) that have not responded to standard treatments. The drug is taken daily by mouth and works by blocking a process cancer cells need to grow. The study …
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC